课题基金 / 基金详情

Investigation and evaluation of genetic polymorphisms of drug metabolizing

Investigation and evaluation of genetic polymorphisms of drug metabolizing
药物代谢基因多态性的调查与评价
批准号:
12470523
负责人:
YOKOI Tsuyoshi
金额:
$7.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

YOKOI Tsuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Identification of genetic polymorphisms had led the profound understanding of the genetic variability in humans. Interindividual variation of drug effects in humans can be attributed in part to the difference in the genes that encoding drug metabolizing enzymes. The reliable genotyping protocols to identify poor metabolizers are already in practice for certain drug-metabolizing enzymes, such as CYP2C9, CYP2C19, CYP2D6, and thiopurine methyltransferase, for the prevention of severe side effects and toxicity from some medications. In this study, there are 3 parts as follows; 1. Relationship between interindividual difference in nicotine metabolism and CYP2A6 genetic polymorphism in humans was proved. Because CYP2A6 catalyzes the metabolism of some pharmaceuticals such as methoxyflurane, halothane, logigamone, the genetic polymorphism of CYP2A6 gene would be clinically important.; 2, Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells were investigated. It is sugge … More sted that a factor contributing to the idiosyncratic hepatptoxicity of troglitazone could be apoptosis in hepatocytes in human. In addition, the formation of a novel quinone epoxide metabolites of troglitazone with cytotoxic to HepG2 cells were studied. Since epoxides are generally regarded as the chemically reactive species, a novel metabolite found in this study may play a role in idiosyncrasy of troglitazone hepatotoxicity via individual differences either in the formation or degradation of this metabolite.; 3, The genetic polymorphism of human organic anion transporters OATP-X (SLC21A6) and OATP-B (SLC21A9) was studied. Allele frequencies in the Japanese population and functional analysis were performed. The frequencies of OATP-C^*1b and OATP-C^*5 alleles were determined as 53.7% and 0.7%, respectively in the Japanese population. Furthermore, a novel allele, OATP-C^*15, was also found with the frequency of 10.3%. The OATP-B^*3 allele was present at high frequency (30.9%) in Japanese and its intrinsic functionality was less than half that of OATP-B^*1. The newly found OATP-B allele as well as OATP-C alleles may influence physiological functions and be one of factors that cause inter-individual variations of drug effects. Less
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
Yui Yamamoto, et al.: "Cytotoxicity and apoptosis produced by troglitazone in human hepatome cells"Life Sci.,. 70. 471-482 (2001)
Yui Yamamoto等人:“曲格列酮在人肝细胞中产生的细胞毒性和细胞凋亡”Life Sci.,。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yui Yamamoto et al.: "Cytotoxicity and apoptosis produced by troglitazone by human henatome cells"Life Sci.. 70. 471-482 (2002)
Yui Yamamoto 等:“曲格列酮对人体细胞产生的细胞毒性和细胞凋亡”Life Sci.. 70. 471-482 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miki Katoh et al.: "Prediction of drug-drug interactions via cytochrome P450 by 1, 4-dihydropyrodine calcium antagonists."Eur.J.Clin.Pharmacol.. 55. 843-852 (2000)
Miki Katoh 等人:“1, 4-二氢吡啶钙拮抗剂通过细胞色素 P450 预测药物间相互作用。”Eur.J.Clin.Pharmacol.. 55. 843-852 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    Establishment of drug hypersensitivity animal model and investigation of the mechanism.
    MicroRNAs as biomarkers for drug-induced liver injury
    • 批准号:
      21390174
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2009
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    Role of microRNA on drug-induced hepatotoxocity
    • 批准号:
      18390049
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.35万
    • 财政年份:
      2006
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    Studies to develop the prediction system for drug metabolism, pharmacokineties and toxicity.
    • 批准号:
      15390172
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2003
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    海外基金